To view the full meeting transcript, please click each day below.
Day 2, Monday, August 10, 2015
Day 3, Tuesday, August 11, 2015
Day 4, Wednesday, August 12, 2015
To view presentation slides, please click the individual titles within each session.
Session 1: Biomarkers in Genitourinary Cancers
Moderator: M. Scott Lucia, MD
Basic Science and The History of Biomarkers
Jack A. Schalken, PhD
The Future of Biomarkers in Prostate and Bladder Cancer
Wim Van Criekinge, PhD
Urology and Social Media
Stacy Loeb, MD
Session 2: Localized Cancer Treatment
Moderator: E. David Crawford, MD
The Future of Focal Therapy
Brian J. Moran, MD
The Future of Robotics
Christopher J. Kane, MD
Session 3: Future Approaches to Prostate, Bladder and Kidney Cancers
Moderator: Daniel P. Petrylak, MD
Radiation Combined with Immunotherapy
Steven E. Finkelstein, MD
Cryotherapy
Fernando J. Kim, MD
ADT
Thomas E. Keane, MD
Management of High Risk Prostate, Kidney and Testis Cancers
Mitchell H. Sokoloff, MD
Checkpoint Inhibitors for Bladder Cancer
Daniel P. Petrylak, MD
Best Decision Markers for Biopsy and Re-Biopsy of the Prostate
E. David Crawford, MD
Session 4: The Future of Castration-Resistant Prostate Cancer: Part 1
Moderator: Raoul S. Concepcion, MD
Hormonal Agents
Leonard G. Gomella, MD
Immunotherapy
Raoul S. Concepcion, MD
Session 5: Genitourinary Cancer Research and Healthcare Coverage
Moderator: Marc B. Garnick, MD
Considerations for Screening
Marc B. Garnick, MD
Session 6: The Future of Men’s and Women’s Urologic Health
Moderator: Karl J. Kreder, MD, MBA
The Future of TRT
Martin Miner, MD
Controversies with TRT
Mohit Khera, MD, MBA, MPH
The Future of Female Urology
Karl J. Kreder, MD, MBA
Session 7: The Future of Castration-Resistant Prostate Cancer: Part 2
Moderator: E. David Crawford, MD
Radiopharmaceuticals
Daniel P. Petrylak, MD
Therapeutics in Advanced Prostate Cancer: The Role of the Urologist
E. David Crawford, MD
ABOUT THE AUTHOR
Researcher-physician E. David Crawford, MD, Jack A. Vickers Director of Prostate Research and Professor of Urology at the University of California, San Diego, has devoted his career in medicine to educating the public about men's health issues and finding effective techniques and procedures to address prostate cancer, the most common malignancy affecting men in the United States.